15 December 2021
3 min read
LIH contributes to international COVID-19 research
Predi-COVID study included in worldwide unCoVer network
In response to the ongoing COVID-19 pandemic, the international unCoVer network plans to exploit available real-world data from numerous partners worldwide to better understand the pathophysiology, progression and treatment, as well as epidemiological pattern of this disease. With its ongoing study Predi-COVID, the Luxembourg Institute of Health (LIH) adds to its existing efforts to combat COVID-19 by joining the unCoVer network, contributing to creating an international, harmonised real-world data bank
“These real-world data allow for studies into patient’s characteristics, risk factors, safety and effectiveness of treatments and potential strategies against COVID-19 in real settings, and complement findings from efficacy/safety clinical trials where vulnerable groups, and patients with comorbidities are often excluded. The unCoVer approach will address urgent questions related to COVID-19 health care provision and develop a secure cross-national database of anonymised hospital data. As the pandemic develops and with the emergence of new viral variants, this will improve patient care and provide the basis for public health initiatives,”
concludes Michel Vaillant, Head of Competence Center for Methodology and Statistics of the LIH Translational Medicine Operations Hub, and contributor to the unCOVer project on behalf of the LIH.
The infrastructure of the unCoVer project was recently published in BMJ Open under the full title “Unravelling data for rapid evidence based response to COVID-19: a summary of the unCoVer protocol.”